Is This Healthcare Stock a Buy for Dividend Growth Investors?
Provided that your portfolio is diversified to properly hedge against the risks associated with investing in stocks, it merely takes time, patience, and some well-thought-out picks to grow richer.
One stock that has worked out considerably well for its investors is LeMaitre Vascular (NASDAQ: LMAT). A $10,000 investment in the niche medical device company made just 10 years ago would now be worth $120,000 with dividends reinvested -- nearly quadruple the S 500's return over that time.
But does LeMaitre have the potential for huge, market-beating returns moving forward? Let's elaborate on the medical device company's fundamentals and valuation to make a judgment.
Source Fool.com
Lemaitre Vascular Inc Aktie
75,50 €
-6,79 %
Noch kein deutliches Sentiment für Lemaitre Vascular Inc mit wenigen Buy- und Sell-Einschätzungen.
Obwohl das Kursziel für Lemaitre Vascular Inc bei 73 € liegt, was unter dem aktuellen Kurs von 75.5 € ist, zeigt sich ein Potenzial von -3.31%.
